TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Upwork Spikes 40% in Its Trading Debut
Play
INVESTING

Microsoft, Qorvo, EA: Analysts' Upgrades and Downgrades

  • By Rob Lenihan
  • Nov 6, 2020 2:20 PM EST
PRESS RELEASES

GBT Initiates Expanded Access Protocol For Oxbryta® (voxelotor) In Pediatric Patients With Sickle Cell Disease In The United States

  • By GlobeNewswire
  • Feb 4, 2021 8:00 AM EST
PRESS RELEASES

European Medicines Agency Accepts GBT's Marketing Authorization Application (MAA) For Oxbryta® (voxelotor) For The Treatment Of Hemolytic Anemia In Sickle Cell Disease

  • By GlobeNewswire
  • Jan 27, 2021 7:00 AM EST
PRESS RELEASES

GBT Announces New Employment Inducement Grants

  • By GlobeNewswire
  • Jan 7, 2021 8:00 AM EST
PRESS RELEASES

GBT Announces Participation At The 39th Annual J.P. Morgan Healthcare Conference

  • By GlobeNewswire
  • Jan 5, 2021 8:00 AM EST
PRESS RELEASES

GBT Announces New Employment Inducement Grants

  • By GlobeNewswire
  • Dec 15, 2020 8:00 AM EST
PRESS RELEASES

GBT Announces Participation In Upcoming Investor Conferences

  • By GlobeNewswire
  • Nov 25, 2020 8:00 AM EST
PRESS RELEASES

GBT Announces Participation At The Stifel 2020 Virtual Healthcare Conference

  • By GlobeNewswire
  • Nov 13, 2020 8:00 AM EST
Upwork Spikes 40% in Its Trading Debut
INVESTING

Microsoft, Qorvo, EA: Analysts' Upgrades and Downgrades

  • By Rob Lenihan
  • Nov 6, 2020 2:20 PM EST
Global Blood Therapeutics Stock Surging on Nordisk Bid Speculation
INVESTING

Global Blood Therapeutics Off on Results Miss, Analyst Rating Cut

  • By Tony Owusu
  • Nov 6, 2020 12:13 PM EST
PRESS RELEASES

GBT Announces Upcoming Virtual Data Presentations At 62nd American Society Of Hematology (ASH) Annual Meeting & Exposition

  • By GlobeNewswire
  • Nov 4, 2020 3:10 PM EST
PRESS RELEASES

GBT Presents Data At 15th Annual Scientific Conference On Sickle Cell And Thalassemia

  • By GlobeNewswire
  • Oct 26, 2020 6:00 AM EDT
PRESS RELEASES

GBT Receives Rare Impact Award For Innovation From The National Organization Of Rare Disorders (NORD) For Development Of Oxbryta® (voxelotor) Tablets

  • By GlobeNewswire
  • Oct 12, 2020 8:00 AM EDT
PRESS RELEASES

GBT Announces New Employment Inducement Grants

  • By GlobeNewswire
  • Oct 5, 2020 8:00 AM EDT
PRESS RELEASES

GBT And Sickle Cell Disease Association Of America To Host 9th Annual Sickle Cell Disease (SCD) Therapeutics Conference

  • By GlobeNewswire
  • Sep 9, 2020 8:00 AM EDT
PRESS RELEASES

GBT And Biopharma-MEA Enter Agreement To Distribute Oxbryta® (voxelotor) In Six Middle Eastern Countries

  • By GlobeNewswire
  • Sep 8, 2020 4:05 PM EDT
PRESS RELEASES

GBT Announces New Employment Inducement Grants

  • By GlobeNewswire
  • Sep 4, 2020 8:00 AM EDT
PRESS RELEASES

GBT Announces Participation In Upcoming Investor Conferences

  • By GlobeNewswire
  • Sep 3, 2020 8:00 AM EDT
PRESS RELEASES

GBT Announces Participation In Upcoming Investor Conferences

  • By GlobeNewswire
  • Jul 30, 2020 8:00 AM EDT
PRESS RELEASES

GBT To Announce Second Quarter 2020 Financial Results On Wednesday, August 5, 2020

  • By GlobeNewswire
  • Jul 29, 2020 8:00 AM EDT
PRESS RELEASES

GBT Announces New Employment Inducement Grants

  • By GlobeNewswire
  • Jul 8, 2020 8:00 AM EDT
PRESS RELEASES

GBT Awards $250,000 In ACCEL Grants To Advance Access To Care For People Living With Sickle Cell Disease

  • By GlobeNewswire
  • Jun 25, 2020 1:00 PM EDT
PRESS RELEASES

GBT Announces Plans To Seek Regulatory Approval For Oxbryta® (voxelotor) To Treat Sickle Cell Patients In Europe

  • By GlobeNewswire
  • Jun 24, 2020 8:30 AM EDT
PRESS RELEASES

MiRagen Strengthens Leadership Team With Appointment Of Lee Rauch As Chief Operating Officer

  • By GlobeNewswire
  • Jun 18, 2020 4:05 PM EDT
PRESS RELEASES

GBT Announces Plans To Seek Expanded Labeling For Oxbryta® (voxelotor) To Treat Children Ages 4 To 11 Years With Sickle Cell Disease

  • By GlobeNewswire
  • Jun 8, 2020 4:05 PM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.